French pharmaceutical firm Pierre Fabre Laboratories signed a landmark deal with China's Sinopharm on Wednesday to advance the commercialization and localization of the company's anti-cancer drugs. This is the first deal in the Chinese mainland since the appointment of Pierre Fabre Medical Care's new CEO earlier this year.

Marie-Andree Gamache, the company's CEO, told CGTN that it sees new opportunities in the Chinese market, with the country set to start its 15th Five-Year Plan (2026-2030).